[Guide to the treatment and care of lymphangioleiomyomatosis].
Hayashida
M
M
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002916:Chylothorax / Q000209:etiology / Q000628:therapy; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D017273:Goserelin / Q000008:administration & dosage; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000209:etiology / Q000628:therapy*; D016040:Lung Transplantation; D018192:Lymphangioleiomyomatosis / Q000209:etiology / Q000628:therapy*; D010052:Ovariectomy; D011030:Pneumothorax / Q000209:etiology / Q000628:therapy; D011374:Progesterone / Q000008:administration & dosage; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy
D018931:Antineoplastic Agents, Hormonal; D001993:Bronchodilator Agents; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D016729:Leuprolide